Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function- associated antigen-3 (LFA-3) expression and not with the CMV-induced down- regulation of cell surface class I HLA

Journal of Immunology

Volumn 161, Issue 5, 1998, Pages 2365-2374

  Fletcher, Jean M ^a   Prentice, H Grant ^a   Grundy, Jane E ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; CYTOTOXICITY TEST; DOWN REGULATION; FIBROBLAST; GLIOBLASTOMA; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; VIRUS STRAIN;

ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; ANTIGENS, CD2; ANTIGENS, CD58; CELL LINE; CYTOMEGALOVIRUS; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; DISEASE SUSCEPTIBILITY; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; FIBROBLASTS; GANCICLOVIR; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, NATURAL; KILLER CELLS, NATURAL; KINETICS; LYMPHOCYTE ACTIVATION; TUMOR CELLS, CULTURED;

EID: 0032168394     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Welsh, R. M., and M. Vargas-Cortes. 1992. Natural killer cells in viral infection. In The Natural Killer Cell. C. E. Lewis and J. O. D. McGee, eds. IRL press, Oxford, U.K., p. 107.
2. Kos, F. J., and E. G. Engleman. 1996. Immune regulation: a critical link between NK cells and CTLs. Immunol. Today 17:174.
3. Bukowski, J. F., B. A. Woda, and R. M. Welsh. 1984. Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice. J. Virol. 52:119.
4. Bukowski, J. F., J. F. Warner, G. Dennert, and R. M. Welsh. 1985. Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo. J. Exp. Med. 161:40.
5. Tay, C. H., and R. M. Welsh. 1997. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J. Virol. 71:267.
6. Quinnan, G. V. J., N. Kirmani, A. H. Rook, J. F. Manischewitz, L. Jackson, G. Moreschi, G. W. Santos, R. Saral, and W. H. Burns. 1982. Cytotoxic T cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. N. Engl. J. Med. 307:7.
7. Venema, H., A. P. van den Berg, C. van Zanten, W. J. van Son, van der Giessen, M, and T. H. The. 1994. Natural killer cell responses in renal transplant patients with cytomegalovirus infection. J. Med. Virol. 42:188.
8. Hokland, M., N. Jacobsen, J. Ellegaard, and P. Hokland. 1988. Natural killer function following allogeneic bone marrow transplantation: very early reemergence but strong dependence of cytomegalovirus infection. Transplantation 45:1080.
9. Bowden, R. A., S. Dobbs, K. J. Kopecky, S. Crawford, and J. D. Meyers. 1988. Increased cytotoxicity against cytomegalovirus-infected target cells by bronchoalveolar lavage cells from bone marrow transplant recipients with cytomegalovirus pneumonia. J. Infect. Dis. 158:773.
10. Biron, C. A., K. S. Byron, and J. L. Sullivan. 1989. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320:1731.
11. Lanier, L. L., B. Corliss, and J. H. Phillips. 1997. Arousal and inhibition of human NK cells. Immunol. Rev. 155:145.
12. Colonna, M. 1997. Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors. Immunol. Rev. 155:127.
13. Moretta, A., R. Biassoni, C. Bottino, D. Pende, M. Vitale, A. Poggi, M. C. Mingari, and L. Moretta. 1997. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol. Rev. 155:105.
14. Ljunggren, H. G., and K. Karre. 1990. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol. Today 11:237.
15. Brutkiewicz, R. R., and R. M. Welsh. 1995. Major histocompatibility complex class I antigens and the control of viral infections by natural killer cells. J. Virol. 69:3967.
16. Karre, K., and R. M. Welsh. 1997. Viral decoy vetoes killer cell. Nature 386:446.
17. 2-microglobulin on the surface of cells infected with cytomegalovirus. J. Gen. Virol. 73:2395.
18. Jones, T. R., and L. Sun. 1997. Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains. J. Virol. 71:2970.
19. Wiertz, E. J., T. R. Jones, L. Sun, M. Bogyo, H. J. Geuze, and H. L. Ploegh. 1996. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84:769.
20. Hengel, H., J. O. Koopmann, T. Flohr, W. Muranyi, E. Goulmy, G. J. Hammerling, U. H. Koszinowski, and F. Momburg. 1997. A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity 6:623.
21. Chee, M. S., A. T. Bankier, S. Beck, R. Bohni, C. M. Brown, R. Cerny, T. Horsnell, C. A. Hutchison, T. Kouzarides, J. A. Martignetti E. Preddie, S. C. Satchwell, et al. 1990. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol. 154:125.
22. Beck, S., and B. G. Barrell. 1988. Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens. Nature 331:269.
23. Reyburn, H. T., O. Mandelboim, M. Vales-Gomez, D. M. Davis, L. Pazmany, and J. L. Strominger. 1997. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 386:514.
24. Starr, S. E., and T. Garrabrant. 1981. Natural killing of cytomegalovirus-infected fibroblasts by human mononuclear leucocytes. Clin. Exp. Immunol. 46:484.
25. + accessory cells in natural killing of cytomegalovirus-infected fibroblasts. J. Exp. Med. 164:180.
26. Waner, J. L., and J. A. Nierenberg. 1985. Natural killing (NK) of cytomegalovirus (CMV)-infected fibroblasts: a comparison between two strains of CMV, uninfected fibroblasts, and K562 cells. J. Med. Virol. 16:233.
27. Borysiewicz, L. K., B. Rodgers, S. Morris, S. Graham, and J. G. Sissons. 1985. Lysis of human cytomegalovirus infected fibroblasts by natural killer cells: demonstration of an interferon-independent component requiring expression of early viral proteins and characterization of effector cells. J. Immunol. 134:2695.
28. Duncombe, A. S., J. E. Grundy, P. Oblakowski, H. G. Prentice, D. J. Gottlieb, D. M. Roy, J. E. Reittie, C. Bello-Fernandez, A. V. Hoffbrand, and M. K. Brenner. 1992. Bone marrow transplant recipients have defective MHC-unrestricted cytotoxic responses against cytomegalovirus in comparison with Epstein-Barr virus: the importance of target cell expression of lymphocyte function-associated antigen 1 (LFA1). Blood. 79:3059.
29. Grundy, J. E., and K. L. Downes. 1993. Up-regulation of LFA-3 and ICAM-1 on the surface of fibroblasts infected with cytomegalovirus. Immunology 78:405.
30. Craigen, J. L., and J. E. Grundy. 1996. Cytomegalovirus induced up-regulation of LFA-3 (CD58) and ICAM-1 (CD54) is a direct viral effect that is not prevented by ganciclovir or foscarnet treatment. Transplantation 62:1102.
31. Grundy, J. E., G. S. Pahal, and A. N. Akbar. 1993. Increased adherence of CD2 peripheral blood lymphocytes to cytomegalovirus-infected fibroblasts is blocked by anti-LFA-3 antibody. Immunology 78:413.
32. MacCormac, L. P., and J. E. Grundy. 1996. Human cytomegalovirus induces an Fc gamma receptor (FcyR) in endothelial cells and fibroblasts that is distinct from the human cellular FcyRs. J. Infect. Dis. 174:1151.
33. Roy, D. M., and J. E. Grundy. 1992. Evaluation of neutralizing antibody titers against human cytomegalovirus in intravenous gamma globulin preparations. Transplantation 54:1109.
34. Bikoue, A., F. George, P. Poncelet, M. Mutin, G. Janossy, and J. Sampol. 1996. Quantitative analysis of leukocyte membrane antigen expression: normal adult values. Cytometry 26:137.
35. Poncelet, P., and P. Carayon. 1985. Cytofluorometric quantification of cell-surface antigens by indirect immunofluorescence using monoclonal antibodies. J. Immunol. Methods 85:65.
36. Lanier, L. L., A. M. Le, C. I. Civin, M. R. Loken, and J. H. Phillips. 1986. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J. Immunol. 136:4480.
37. Sentman, C. L., M. Y. Olsson, and K. Karre. 1995. Missing self recognition by natural killer cells in MHC class I transgenic mice: a 'receptor calibration' model for how effector cells adapt to self. Semin. Immunol. 7:109.
38. Ljunggren, H. G., K. Sturmhofel, E. Wolpert, G. J. Hammerling, and K. Karre. 1990. Transfection of beta 2-microglobulin restores IFN-mediated protection from natural killer cell lysis in YAC-1 lymphoma variants. J. Immunol. 145:380.
39. Davis, S. J., and P. A. van der Merwe. 1996. The structure and ligand interactions of CD2: implications for T-cell function. Immunol. Today 17:177.
40. 3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor. J. Immunol. 136:3939.
41. Schmidt, R. E., J. P. Caulfield, J. Michon, A. Hein, M. M. Kamada, R. P. MacDermott, R. L. Stevens, and J. Ritz. 1988. T11/CD2 activation of cloned human natural killer cells results in increased conjugate formation and exocytosis of cytolytic granules. J. Immunol. 140:991.
42. Scott, C. F., Jr., S. Bolender, G. D. McIntyre, J. Holldack, J. M. Lambert, Y. P. Venkatesh, C. Morimoto, J. Ritz, and S. F. Schlossman. 1989. Activation of human cytolytic cells through CD2/T11: comparison of the requirements for the induction and direction of lysis of tumor targets by T cells and NK cells. J. Immunol. 142:4105.
43. Moretta, A., A. Poggi, D. Pende, G. Tripodi, A. M. Orengo, N. Pella, R. Augugliaro, C. Bottino, E. Ciccone, and L. Moretta. 1991. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor α/β. J. Exp. Med. 174:1393.
44. Lanier, L. L., J. J. Ruitenberg, and J. H. Phillips. 1988. Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes. J. Immunol. 141:3478.
45. Bezouska, K., C. T. Yuen, J. O'Brien, R. A. Childs, W. Chai, A. M. Lawson, Drbal, K, A. Fiserova, M. Pospisil, and T. Feizi. 1994. Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity. [Published erratum appears in 1996 Nature 380:559.] Nature 372:150.
46. Sivori, S., M. Vitale, L. Morelli, L. Sanseverino, R. Augugliaro, C. Bottino, L. Moretta, and A. Moretta. 1997. p46, a novel natural killer cell-specific surface molecule that mediates cell activation. J. Exp. Med. 186:1129.
47. Cosman, D., N. Fanger, L. Borges, M. Kubin, W. Chin, L. Peterson, and M. L. Hsu. 1997. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7:273.
48. Fitzgerald, P. A., P. Von Wussow, and C. Lopez. 1982. Role of interferon in natural kill of HSV-1 infected fibroblasts. J. Immunol. 129:819.
49. Bishop, G. A., J. C. Glorioso, and S. A. Schwartz. 1983. Role of interferon in human natural killer activity against target cells infected with HSV-1. J. Immunol. 131:1849.